(Q51580711)
Statements
Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days (English)
1 reference
Desager JP
1 reference
Horsmans Y
1 reference
Vandenplas C
1 reference
Harvengt C
1 reference
1 July 1996
1 reference
124 Suppl
1 reference
S65-73
1 reference